MDClone, a Be’er Sheva, Israel-based digital health company, raised $63m in Series C funding.
The round was led by Warburg Pincus and Viola Growth, with participation from existing investors aMoon, LightSpeed Venture Partners, and OrbiMed.
The company intends to use the funds to accelerate the expansion of its healthcare data solutions by investing in new regional markets, continuing to develop the existing platform and expanding into new vertical markets including Life Science and Real World Evidence (“RWE”), and to hire a number of key roles as it looks to continue to advance data access and accelerate the power of self-service data exploration.
Led by Ziv Ofek, Co-Founder and CEO, MDClone provides clinicians and healthcare professionals with the ability to explore healthcare data independently and without barriers. The MDClone ADAMS Platform is a data analytics environment, encouraging self-service data exploration and action across teams in a healthcare ecosystem – resulting in operational efficiencies, revenue growth and proactive care for patients around the world.
Founded in Israel in 2016, the company serves major health systems, payers, and life science customers in the United States, Canada, and Israel.